Appointment of Marc Le Bozec as Interim CEO
Appointment of Marc Le Bozec as Interim CEO Nantes, October 3, 2025,…
Update on Information Relating to the General Meeting of September 30, 2025
Update on Information Relating to the General Meeting of September 30, 2025…
OSE Immunotherapeutics met jour linformation sur les procdures en cours
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2,…
OSE Immunotherapeutics Publishes Letter to Shareholders
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00…
